Werewolf Therapeutics Ownership | Who Owns Werewolf Therapeutics?
Werewolf Therapeutics Ownership Summary
Werewolf Therapeutics is owned by 49.66% institutional investors, 5.96% insiders, and 44.39% retail investors. Ra capital management is the largest institutional shareholder, holding 14.85% of HOWL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.93% of its assets in Werewolf Therapeutics shares.
HOWL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Werewolf Therapeutics | 49.66% | 5.96% | 44.39% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Ra capital management | 6.68M | 14.85% | $7.28M |
Mpm asset management | 4.31M | 9.58% | $4.70M |
Bioimpact capital | 2.41M | 5.36% | $2.63M |
Bank of america corp /de/ | 2.15M | 5.16% | $5.24M |
Blackrock | 1.59M | 3.82% | $3.87M |
Vanguard group | 1.42M | 3.25% | $2.10M |
Millennium management | 784.62K | 1.75% | $762.80K |
Geode capital management | 702.56K | 1.61% | $1.04M |
Sphera funds management | 626.81K | 1.39% | $683.22K |
Dc funds, lp | 589.10K | 1.31% | $642.12K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Dc funds, lp | 589.10K | 29.83% | $642.12K |
Mpm asset management | 4.31M | 10.84% | $4.70M |
Bioimpact capital | 2.41M | 0.45% | $2.63M |
Sphera funds management | 626.81K | 0.16% | $683.22K |
Ra capital management | 6.68M | 0.12% | $7.28M |
Pfm health sciences, lp | 401.11K | 0.04% | $437.21K |
Point72 asia (singapore) pte. | 20.13K | 0.00% | $21.94K |
Bridgeway capital management | 109.59K | 0.00% | $162.19K |
Two sigma securities | 22.41K | 0.00% | $24.43K |
Y-intercept (hong kong) | 84.42K | 0.00% | $92.02K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 1.59M | 0.00% | 1.42M |
Ra capital management | 6.68M | 0.12% | 536.43K |
Bank of america corp /de/ | 2.15M | 0.00% | 266.31K |
Millennium management | 784.62K | 0.00% | 188.33K |
Marshall wace, llp | 103.78K | 0.00% | 103.78K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Pfm health sciences, lp | 401.11K | 0.04% | -2.11M |
Adage capital partners gp | - | - | -2.00M |
Rubric capital management lp | - | - | -1.33M |
Blackrock funding, inc. /de | 361.98K | - | -1.31M |
Monashee investment management | - | - | -890.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Marshall wace, llp | 103.78K | 0.00% | 103.78K | $113.13K |
Y-intercept (hong kong) | 84.42K | 0.00% | 84.42K | $92.02K |
Qube research | 44.26K | - | 44.26K | $48.24K |
Hrt financial lp | 42.48K | 0.00% | 42.48K | $46.00K |
Susquehanna group, llp | 33.86K | - | 33.86K | $50.12K |
Sold Out
Holder | Change |
---|---|
Ifp advisors | -1.00 |
Nisa investment advisors | -40.00 |
Capital performance advisors llp | -60.00 |
Russell investments group | -86.00 |
Point72 (difc) | -381.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 65 | -9.72% | 22,335,903 | -18.62% | 49 | 1.32% | 32 | 3.23% | 19 | -5.00% |
Mar 31, 2025 | 1 | -98.65% | 1,333,893 | -95.26% | 2 | 0.07% | - | -100.00% | - | -100.00% |
Dec 31, 2024 | 45 | -35.71% | 5,479,410 | -82.99% | 12 | 0.23% | 28 | -28.21% | 8 | -33.33% |
Sep 30, 2024 | 69 | -4.17% | 31,964,492 | -0.84% | 73 | 1.22% | 38 | -15.56% | 12 | -7.69% |
Jun 30, 2024 | 72 | 14.29% | 32,236,039 | -0.05% | 77 | 1.00% | 45 | 15.38% | 13 | 8.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 876.59K | 1.93% | -19.16K |
Vanguard US Total Market Shares ETF | 800.28K | 1.79% | - |
HBM Healthcare Investments AG Ord | 396.80K | 0.91% | -60.51K |
Fidelity Small Cap Index | 311.53K | 0.69% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 284.82K | 0.63% | -107.34K |
BIT Biotech Opportunities S | 241.06K | 0.54% | - |
Fidelity Extended Market Index | 167.37K | 0.37% | -437.00 |
Vanguard Russell 2000 ETF | 152.99K | 0.34% | 1.40K |
Royce Micro Cap Trust | 125.48K | 0.29% | 88.16K |
A4Investments SICAV SIF ACCI IlanaA2EURH | 117.75K | 0.26% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 12, 2025 | RA CAPITAL MANAGEMENT, L.P. | Buy | $275.99K | |
May 13, 2025 | RA CAPITAL MANAGEMENT, L.P. | Buy | $51.91K | |
May 14, 2025 | RA CAPITAL MANAGEMENT, L.P. | Buy | $159.29K | |
Mar 27, 2025 | MPM BioVentures 2014, L.P. | - | Sell | $2.06K |
Mar 27, 2025 | EVNIN LUKE | Sell | $2.55K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 3 | - |
2025 Q1 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q2 | - | - |
HOWL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools